MGPI Stock Cash Flow Statements

MGP Ingredients Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

MGP Ingredients Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2022-03-31	2021-03-31	2020-03-31	2019-03-31	2018-03-31	2015-03-31	2014-03-31	2012-03-31	2011-09-30	2010-09-30	2009-09-30

cash flows from operating activities
net income	37,371,000	15,427,000	9,842,000	9,720,000	8,927,000	5,070,000	4,785,000	1,876,000	-5,509,000	5,002,000	3,738,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	5,621,000	3,311,000	3,125,000	2,810,000	2,929,000	3,091,000	3,042,000	2,935,000	2,387,000	2,007,000	2,250,000
share-based compensation	1,373,000	3,229,000	1,139,000	1,125,000	1,191,000
equity method investment gain
deferred income taxes, including change in valuation allowance	347,000	-648,000	101,000	145,000
change in fair value of contingent consideration
other	24,000	-380,000	128,000		-62,000	120,000	-230,000		570,000		684,000
changes in operating assets and liabilities:
receivables	-9,601,000	-4,348,000	-11,453,000	-5,088,000	-185,000	-194,000	-4,050,000	-7,984,000	-3,169,000
inventory	-13,696,000	4,924,000	-5,649,000	-2,561,000	-5,727,000	-3,213,000	4,042,000	-3,236,000	-1,908,000		3,415,000
prepaid expenses	657,000	-1,084,000	-2,339,000	-943,000	-1,005,000	-564,000	-942,000	-409,000	95,000
income taxes payable	5,437,000	5,237,000	3,100,000		1,048,000
accounts payable	4,638,000	509,000	1,635,000	-3,976,000	-2,238,000	819,000	-3,352,000	-1,880,000	-2,670,000
accrued expenses and other	-8,896,000	-8,385,000
federal and state excise taxes payable	-515,000
net cash from operating activities	22,230,000	16,990,000	542,000	-3,789,000	879,000	6,121,000	-642,000	-10,971,000	-13,948,000		3,250,000
capex	-10,642,000	-12,059,000	-5,645,000	-3,741,000	-6,978,000	-5,030,000	-2,182,000	-484,000	-384,000		0
free cash flows	11,588,000	4,931,000	-5,103,000	-7,530,000	-6,099,000	1,091,000	-2,824,000	-11,455,000	-14,332,000		3,250,000
cash flows from investing activities
additions to property, plant, and equipment	-10,642,000	-12,059,000	-5,645,000	-3,741,000
net cash from investing activities	-12,033,000	-13,340,000	-8,189,000	-4,907,000	-7,040,000	-5,030,000	-2,182,000	10,351,000	-323,000		1,127,000
cash flows from financing activities
payment of dividends and dividend equivalents	-2,661,000	-2,052,000	-2,060,000	-1,714,000	-1,375,000
repurchase of common stock
loan fees paid related to borrowings			-1,148,000
proceeds from long-term debt
principal payments on long-term debt	-807,000		-100,000	-95,000	-93,000	-398,000	-384,000	-413,000	-474,000
net cash from financing activities	-4,182,000	-2,726,000	46,997,000	3,671,000	4,200,000	-341,000	-33,000	237,000	7,654,000	1,343,000
effect of exchange rate changes on cash and cash equivalents
increase in cash and cash equivalents	5,727,000	924,000	39,350,000			750,000		-383,000
cash and cash equivalents, beginning of period	21,568,000	21,662,000	3,309,000	5,025,000	3,084,000
cash and cash equivalents, end of period	27,295,000	22,586,000	42,659,000		1,123,000	6,391,000			986,000	157,000
impairment of long-lived assets and other
goodwill impairment
changes in operating assets and liabilities, net of effects of acquisitions:
purchase of business, net of cash acquired
contributions to equity method investments
cash and cash equivalents, beginning of year						5,641,000	2,857,000	383,000	7,603,000	6,369,000	178,000
cash and cash equivalents, end of year
changes in operating assets and liabilities, net of effects of acquisition:
equity method investment loss
gain on insurance recoveries
proceeds from property insurance recoveries
purchase of treasury stock	-714,000	-674,000	-4,395,000				-104,000		-84,000
loan fees incurred with borrowings						-291,000
proceeds from credit agreement - revolver			54,700,000	11,025,000
payments on credit agreement - revolver
proceeds from convertible senior notes
payment on assumed debt as part of the merger
contributions to equity method investment	-1,028,000
proceeds from sale of property and other
refundable income taxes				-1,649,000			208,000	120,000
effect of exchange rate changes on cash	-288,000
gain on equity method investment	-394,000
gain on sale of assets			-9,000	-138,000						289,000
federal and state liquor taxes payable
proceeds from sale of property			366,000
net income attributable to noncontrolling interest
unrealized gain on foreign currency
loss on sale of assets								48,000
deferred credits		-802,000	-81,000	-83,000
acquisition of business			-2,750,000
accrued expenses			1,003,000	-3,140,000	-4,009,000	-1,248,000	-1,951,000	904,000	-389,000		387,000
deferred compensation plan investments				-1,166,000
gain on sale of equity method investment
distributions received from equity method investee
accounts payable to affiliate						685,000	1,360,000	-1,380,000	-1,546,000
divestiture of equity method investment
purchase of treasury stock for tax withholding on equity-based compensation				-5,467,000
accrued retirement health, and life insurance benefits				-11,000
proceeds on long-term debt
decrease in cash and cash equivalents				-5,025,000	-1,961,000		-2,857,000		-6,617,000
gain on property insurance recoveries
equity method investment (earnings) loss							-3,334,000
accrued retirement, health, and life insurance benefits
acquisition of george remus®
increase in cash
cash, beginning of year
cash, end of year
balance, december 31, 2015
comprehensive income:
other comprehensive income
dividends and dividend equivalents, net of estimated forfeitures
stock shares awarded, forfeited or vested
stock shares repurchased
balance, december 31, 2016
balance, december 31, 2017
balance, december 31, 2018
deferred income taxes					279,000	2,027,000
income taxes payable/refundable
deferred credit					-217,000	-160,000	-155,000	-150,000	-152,000
accrued retirement health and life insurance benefits					-114,000
additions to plant, property and equipment					-6,978,000
return of equity method investment
purchase of treasury stock for tax withholding on share-based compensation					-2,073,000
proceeds from credit agreement					7,741,000
payments on credit agreement
equity method investment earnings						-1,352,000
distribution received from equity method investee
payment of dividends
principal payments on credit agreement
balance, december 31, 2014
excess tax benefits
proceeds from credit facility
payments on credit facility
inventory, net of assets acquired in acquisition
additions to property and equipment						-5,030,000	-2,182,000	-484,000	-384,000
divestiture of dmi
balance, december 31, 2013
other comprehensive loss
stock shares repurchased for payment of taxes
balance, december 2014
balance, december 2015
balance, december 2016
gain on sale of bioplastics manufacturing business
share based compensation						205,000	149,000	353,000	176,000
restricted cash								1,454,000	-7,140,000	971,000	200,000
accrued retirement health and life insurance benefits, pension obligations, and other noncurrent liabilities
proceeds from sale of bioplastics manufacturing business
principal payments on credit facility
balance, december 31, 2012
comprehensive loss:
dividends paid
accrued retirement health and life insurance benefits and other accrued retiree benefits
loss on property insurance recoveries
accrued retirement health and life insurance benefits and other noncurrent liabilities						-127,000	-214,000	-261,000	-85,000
proceeds from revolving credit facility						1,086,000	14,776,000	43,756,000	104,982,000
payments on revolving credit facility						-738,000	-14,321,000
accrued income taxes						962,000
gains on property insurance recoveries
release of valuation allowance for deferred tax assets
gain on sale of joint venture interest								-4,055,000
loss/(gain) on sale of assets
equity in loss
change in derivatives								1,131,000
investments in/ advances to equity method investments
proceeds from sale of interest in icp
proceeds from disposition of property and equipment
principal payments on revolving credit facility								-43,106,000	-96,770,000
equity in (earnings) loss of joint ventures									2,830,000
net cash from (used by) operating activities
proceeds from sale of joint venture interest								9,103,000
proceeds from the disposition of property and equipment								2,232,000	61,000
investment in and advances to unconsolidated subsidiaries								-500,000
net cash from (used by) investing activities
net cash from (used by) financing activities
bargain purchase gain, net of tax
loss on impairment of assets
changes in operating assets and liabilities, net of acquisition:
acquisition of ldi’s distillery business
proceeds from stock plans
exercise of stock options
proceeds from issuance of long-term debt
equity in earnings of joint ventures								-437,000
loss on joint venture formation
equity in loss of joint ventures
gains previously deferred in other comprehensive income
investments in/ advances to joint ventures
proceeds from sale of interest in joint venture
tax effect of restricted stock awards
change in derivative valuation									2,562,000
accrued retirement health and life insurance benefits and other non-current liabilities
investment in/advances to joint ventures
proceeds from sale of interest in joint ventures
income taxes payable/receivable											42,000
accrued retirement health and life insurance benefits and other non current liabilities
proceeds from long-term debt and capital leases											2,032,000
proceeds from line of credit										62,335,000	49,273,000
principal payments on line of credit
changes in working capital items:
investments in/ advances to joint venture
adjustments to reconcile net income to net cash used by operating activities:
joint venture operations loss
accrued natural gas derivative
income taxes payable / refundable
accrual for retirement benefits and other non-current liabilities
tax effect of restricted stock awarded
proceeds from revolving line of credit
principal payments on revolving line of credit
joint venture operations
receivables/receivables from affiliate
accounts payable/accounts payable to affiliate
accrued retirement benefits and other non-current liabilities
equity in loss of joint venture											48,000
accounts receivable
other non-current liabilities
proceeds from sale of assets											1,127,000
principal payments on long-term debt and capital leases
loss on write-off of assets
investments in and advances to joint venture
proceeds from disposition of equipment
impairment of long lived assets
accrual for natural gas derivative
accounts payable and accrued expenses
write-off of assets
deferred revenue
segregated cash and investments
inventories
net proceeds from line of credit
items not requiring (providing) cash:
changes in:
stock repurchased
depreciation
gain on insurance recovery
items not requiring cash
gain on sale/conversion of property and equipment
insurance receivable
deferred income
income taxes receivable
proceeds from sale/conversion of property and equipment
payments on long-term debt
stock compensation
income taxes (receivable) payable
exercise and vesting of stock options
net proceeds on line of credit
dividends payable
sale of treasury stock
operating activities
income taxes receivable/payable
investing activities
insurance proceeds from property damage
financing activities
sales of treasury stock
borrowings on line of credit
changes in
proceeds from sale/conversion of equipment
net payments on long-term debt
net purchases of investments
items not requiring (providing) cash
net proceeds from disposition of investments
financing activities;
net proceeds from issuance of long-term debt

We provide you with 20 years of cash flow statements for MGP Ingredients stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of MGP Ingredients stock. Explore the full financial landscape of MGP Ingredients stock with our expertly curated income statements.

The information provided in this report about MGP Ingredients stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.